Clinical trial
A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics…
NCT00000391 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00000391 |
|---|---|
| Title | A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients. |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Peptide T |
| Enrollment | 30 |
| Start date | Jan 1, 1988 |
| Primary completion | Jan 1, 1990 |
| First posted | Jan 18, 2000 |
| Last update posted | Mar 3, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: